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LINICAL RESEARCH Resynchronization and M-Mode Echo
eptal to Posterior Wall
otion Delay Fails to Predict Reverse
emodeling or Clinical Improvement in
atients Undergoing Cardiac Resynchronization Therapy
regory M. Marcus, MD,* Emily Rose, MD,† Esperanza M. Viloria, BS,* Jill Schafer, MS,‡
eresa De Marco, MD, FACC,* Leslie A. Saxon, MD, FACC,§ Elyse Foster, MD, FACC,*
or the VENTAK CHF/CONTAK-CD Biventricular Pacing Study Investigators
an Francisco and Los Angeles, California; Boston, Massachusetts; and St. Paul, Minnesota
OBJECTIVES The aim of this study was to test the hypothesis that a longer septal-to-posterior wall motion
delay (SPWMD) would predict greater reverse remodeling and an improved clinical response
in heart failure patients randomized to cardiac resynchronization therapy (CRT) in the
CONTAK-CD trial.
BACKGROUND The SPWMD predicted clinical benefit with CRT in two previous studies from the same
center.
METHODS In this retrospective analysis of the CONTAK-CD trial, SPWMD was measured from the
baseline echocardiogram of 79 heart failure patients (ejection fraction 22  7%, QRS
duration 159  27 ms, 72% ischemic, 84% male) randomized to CRT and compared with
six-month changes in echocardiographic and clinical parameters. Patients with a left
ventricular end-systolic volume index (LVESVI) reduction of at least 15% were considered
responders.
RESULTS The feasibility and reproducibility of performing the SPWMD measurements were poor.
Larger values for SPWMD did not correlate with six-month changes in left ventricular
end-diastolic volume index (p  0.26), LVESVI (p  0.41), or left ventricular ejection
fraction (p  0.36). Responders did not have a significantly different SPWMD than
non-responders (p  0.26). The SPWMD did not correlate with measures of clinical
improvement. At a threshold of SPWMD130 ms, the test characteristics to predict reverse
remodeling or a clinical response were inadequate.
CONCLUSIONS The previous findings that SPWMD predicts reverse remodeling or clinical improvement
with CRT were not reproducible in patients randomized in the CONTAK-CD trial. (J Am
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.05.095Coll Cardiol 2005;46:2208–14) © 2005 by the American College of Cardiology Foundation
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6ntraventricular conduction delay, primarily in the form of
eft bundle-branch block, is present in approximately 25% of
eart failure patients (1). The resultant delayed and dyssyn-
hronous left ventricular (LV) contraction worsens ventric-
lar function and results in increased myocardial oxygen
emand, ventricular remodeling, and increased mortality
2–4).
By simultaneously stimulating the right ventricle and the
ree wall of the LV, cardiac resynchronization therapy (CRT)
as been shown to decrease LV volumes and dimensions,
From *Department of Medicine, Division of Cardiology, University of California,
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uidant Corporation, Medtronic, and St. Jude Corporations. Ms. Schafer is an
mployee of Guidant Corporation. The first two authors contributed equally to this
aper.t
Manuscript received March 1, 2005; revised manuscript received May 8, 2005,
ccepted May 15, 2005.ncrease ejection fraction, and improve functional status in
ome, but not all patients with severe LV systolic dysfunc-
ion, interventricular conduction delay, and symptomatic
eart failure (5,6). In previous studies, a greater degree of
lectrical and mechanical dyssynchrony at baseline have
een associated with greater likelihood of improvement in
V structure and function with CRT (7,8).
Current inclusion criteria for CRT devices use only the
RS duration to assess dyssynchrony. Given the costs and
isks associated with CRT, identifying reliable non-invasive
easures of ventricular dyssynchrony that predict therapeu-
ic benefit are needed to optimize patient selection.
In a non-randomized study of 20 CRT patients with pre-
ominantly non-ischemic cardiomyopathy, it was demon-
trated that septal-to-posterior wall motion delay (SPWMD)
easured by M-mode echocardiography was a useful pre-
ictor of reverse remodeling (9). More recently, a study of
0 CRT patients from the same center demonstrated that
he SPWMD was useful to predict heart failure progression.
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December 20, 2005:2208–14 SPWMD Fails to Predict CRT Outcomesn both studies, a longer SPWMD was associated with
reater improvement with CRT, and a SPWMD 130 ms
as found to be a useful cutoff point to predict success.
ased on these results, SPWMD has been suggested as a
creening method for patient selection for CRT. However,
he feasibility and utility of this parameter have not been
ested in a largely ischemic population in whom endocardial
xcursion of either the septal or posterior wall may be
arkedly diminished and therefore not clearly identifiable.
This study was designed to test the hypothesis that
PWMD would predict greater reverse remodeling and an
mproved clinical response in heart failure patients random-
zed to CRT in the CONTAK-CD trial.
ETHODS
ubjects. The VENTAK CHF/CONTAK-CD study en-
olled 581 patients from 47 investigational centers through-
ut the U.S. from February 1998 through December 2000.
he study was approved by the institutional review board at
ach participating institution, and patients gave written
nformed consent. Inclusion criteria were an indication at
he time of enrollment for an implantable cardioverter
efibrillator, symptomatic heart failure despite optimal drug
herapy, left ventricular ejection fraction (LVEF) 35%, a
RS duration 120 ms; age 18 years, and normal sinus
ode function. The exclusion criteria and study design have
een described in a previous publication (5). Originally, all
atients received a CRT device and were randomized to
RT turned on or to CRT turned off (phase 1, n  248).
ecause of regulatory concern, the study was modified from
crossover to a six-month parallel design in phase 2 (n 
33). Of the 581 patients enrolled between the two phases,
01 were successfully implanted with the investigational
ystem (5). Only phase 2 patients randomized to CRT
urned on with paired baseline and six-month echo data are
ncluded in this analysis.
chocardiographic analysis. Two-dimensional Doppler
chocardiograms were performed at multiple investigational
ites according to a standardized protocol at baseline, three
onths, and six months after randomization. For the
urposes of this study, the baseline and six-month echocar-
iograms were analyzed. A two-dimensionally guided (M-
ode) echocardiogram at a level just below the tips of the
itral leaflets, basal to the tips of the papillary muscles, was
sed for measurement of the SPWMD as described subse-
Abbreviations and Acronyms
CRT  cardiac resynchronization therapy
LV  left ventricle/ventricular
LVEDVI  left ventricular end-diastolic volume index
LVEF  left ventricular ejection fraction
LVESVI  left ventricular end-systolic volume index
NYHA  New York Heart Association
SPWMD  septal-to-posterior wall motion delayuently. Left ventricular end-diastolic volumes and LV end- lystolic volumes were obtained by tracing the endocardium at
he end-diastole (maximum cavity dimension) and end-
ystole (frame before mitral valve opening or the minimum
avity area) in the two-chamber and four-chamber views
nd derived according to Simpson’s rule (biplane method of
iscs) (10). The left ventricular end-systolic volume index
LVESVI) and left ventricular end-diastolic volume index
LVEDVI) are normalized for body surface area. The
VEF was calculated as the total stroke volume divided by the
nd-diastolic volume. Echocardiograms were excluded when
ess than 80% of the endocardium could be visualized. Re-
ponders were defined as those who had greater than a 15%
ecrease in LVESVI (9,11). Clinical improvement measures
ncluded six-month change in peak exercise O2 consumption,
-min walk distance, quality of life score as assessed by the
innesota Living with Heart Failure Questionnaire, and New
ork Heart Association (NYHA) functional class.
The SPWMD represents the delay between the motion
f the septum and the posterior wall of the LV. We adopted
he method described by Pitzalis et al. (9) and measured the
PWMD on the M-mode echocardiogram obtained at
aseline before randomization: the maximum displacement
f the septal wall and the maximum displacement of the
osterior wall were both measured from the onset of the
RS; the QRS to septal wall deflection value was then
ubtracted from the QRS to posterior wall deflection value
o calculate the SPWMD (Fig. 1). Three measurements
ere made for each parameter and then averaged. These
easurements were performed for each subject by two
ndependent observers for 60% of the subjects for the
rimary and first observer and 47% of the subjects for the
rimary and second observer. In adopting this method, we
ecognize that the level of M-mode echocardiogram differs
rom the original description (9): Pitzalis obtained the
-mode at the level of the papillary muscles. In contrast,
he measurements for the present study were made at a more
asal level, representing the standard location for measuring
V dimensions.
The ability to accurately measure SPWMD on the
-mode tracing was highly dependent on the extent of
xcursion of the septal and posterior walls. Therefore, a scale
f difficulty was created. A value of one was given if both the
eptal wall and the posterior wall deflection were easily
isualized. A value of two was given if either the septal or
osterior wall displacement was difficult to visualize. A value
f three was given if both the septal and posterior wall were
ifficult to visualize or if either one had no identifiable
eflection.
Operators blinded to the success of resynchronization
herapy for the individual patients performed the echocar-
iographic analysis of intraventricular dyssynchrony. Inter-
bserver reliability was measured with two independent
bservers compared with the primary observer.
tatistical analysis. Linear comparisons between SPWMD
nd LVESVI, LVEDVI, and LVEF were made by calcu-
ating the Pearson product-moment correlation coefficient.
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SPWMD Fails to Predict CRT Outcomes December 20, 2005:2208–14ifferences in categorical and continuous variables between
esponders and non-responders were assessed by the chi-
quare test or Student t test, as appropriate. In addition,
ix-month change in peak exercise O2 consumption, 6-min
alk distance, quality of life score, and NYHA functional
lass were correlated with all dyssynchrony parameters. To
eveal whether patients with longer baseline SPWMD
easurements experienced a significantly greater improve-
ent in LVESVI, LVEDVI, and LVEF with CRT than
ther patients, linear regressions with respect to these
ariables and their effect on treatment group were per-
ormed. To be consistent with previous studies, a SPWMD
alue 130 ms was used to determine the sensitivities,
pecificities, and positive and negative predictive values for
ix-month improvement in echocardiographic and clinical
arameters (8,9). In determining associations between pa-
ients with and without a SPWMD 130 ms and clinical
utcomes, continuous measures were calculated from a
tudent t test and values for categorical measures were
alculated by a chi-square test.
Within-subjects standard deviation was calculated using
he analysis of variance between the two independent observers
nd compared with the primary observer, and repeatability
f measurements was calculated by multiplying the within-
ubjects standard deviation by 2.77 to account for 2 SD
rom the mean and two independent measurements of the
ame value (12–14).
ESULTS
f the 333 subjects randomized to CRT in the
ONTAK-CD trial, six-month echocardiograms were avail-
ble for 79 (24%) (Table 1). Compared with subjects for
hom six-month echocardiograms were not available, those
ith both baseline and six-month echocardiograms had no
ignificant differences in regard to gender, etiology of heart
igure 1. Septal wall motion delay (SWMD) was measured in M-mode b
osterior wall motion delay (PWMD) was measured similarly by measuri
ifference between the septal wall deflection and the posterior wall deflectailure, QRS duration, and ejection fraction (Table 1). aubjects for whom six-month echocardiograms were not
vailable were less likely to be taking a beta-blocker and
ere less likely to have a lateral lead location.
easibility of the SPWMD measurements. A definitive
ystolic deflection of both the septal and posterior walls was
vident in less than half of all subjects (45%). According to
he difficulty scale, the number of patients in each category
as: 1 (n  39), 2 (n  27), and 3 (n  13). The level of
ifficulty scale did not influence relationships between
yssynchrony parameters and CRT benefit in any category.
eproducibility of SPWMD measurements. There was
oor inter-observer precision of SPWMD (observer 1 with
he primary observer 141 ms, n 37; observer 2 with the
rimary observer  194 ms, n  47). For example, the
ithin-subjects standard deviation for SPWMD between
bserver 1 and the primary observer was 51 ms, yielding a
epeatability of 141 ms. These suggest that 95% of pairs of
easurements of the same echocardiographic parameter by
ifferent observers should fall between 141 ms.
orrelations between baseline SPWMD and six-month
vidence of reverse remodeling. The reduction in LVESVI
nd LVEDVI and the improvement in ejection fraction
ere determined by comparing the baseline and six-month
chocardiograms. Baseline SPWMD did not correlate with
ix-month changes in LVESVI (0.10, p  0.41),
VEDVI (0.14, p 0.26), or ejection fraction (0.11, p
.36). Correlations remained non-significant when examin-
ng the same echocardiographic parameters in patients with
nd without ischemic etiologies of heart failure.
The baseline SPWMD did not significantly differ be-
ween responders (mean 77  141 ms, range 340 ms to
12 ms) and non-responders (mean 59  160, range 326
s to 525 ms, p  0.63). The lack of any relationship
etween baseline SPWMD and responders persisted when
xamining patients with ischemic etiologies of heart failure
suring from the start of the QRS to the peak of the septal wall deflection.
m the start of the QRS to the peak of the posterior wall deflection. The
the septal-to-posterior wall motion delay (SPWMD).y mealone or non-ischemic etiologies of heart failure alone. Pa-
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December 20, 2005:2208–14 SPWMD Fails to Predict CRT Outcomesients with a SPWMD 130 ms did not have significantly
mproved six-month changes in LVESVI, LVEDVI, or
jection fraction compared with those with SPWMD130
s; again, this finding was independent of heart failure
tiology. In addition, the test characteristics for a SPWMD
130 ms to predict a responder were poor (Table 2).
orrelation between baseline SPWMD and measures of
linical improvement. Baseline SPWMD parameters did
ot significantly correlate with six-month change in oxygen
onsumption (0.04, p  0.75), six-month change in
-min walk (0.06, p  0.59), six-month change in quality
f life (0.11, p  0.32), or six-month change in NYHA
unctional class (0.06, p  0.54). Patients with a SPWMD
130 ms were no more likely to have six-month improve-
ent in any of the clinical parameters (Table 3). The test
haracteristics for a SPWMD 130 ms to predict an
mprovement in at least one NYHA functional class were
oor (Table 2).
In the linear regression analyses, no significant interac-
ions between SPWMD and CRT with respect to improve-
ents in LVESVI, LVEDVI, and LVEF were found.
ISCUSSION
ith respect to reverse remodeling, systolic function, and
mprovements in clinical outcomes, SPWMD as deter-
ined by M-mode echocardiography did not predict a
esponse to CRT in this group of patients. We do not
elieve that our findings bear any reflection on the validity
f the concept that true baseline LV dyssynchrony itself
ight predict benefit with CRT. Instead, contrary to
revious publications, we believe our data demonstrate that
-mode SPWMD does not provide a reliable or accurate
eflection of actual LV dyssynchrony.
Primarily, the limited feasibility of obtaining the nec-
ssary M-mode measurements in order to calculate the
PWMD suggests that this method of screening for CRT
election would likely not be applicable in clinical practice.
n this cohort, nearly one-half (45%) of patients had neither
definitive septal nor posterior wall deflection visualized on
able 1 Continued
Characteristic
Paired Echo
(n  79)
No Paired Echo
(n  69)
p
Value
eft anterior oblique view lead
position, n (%)
Anterior 16 (21.1) 50 (35.0) 0.02
Lateral 54 (71.1) 73 (51.0)
Posterior 6 (7.9) 20 (14.0)
nterior-posterior view lead
position, n (%)
Apical 9 (11.8) 18 (12.6) 0.97
Basal 7 (9.2) 14 (9.8)
Mid 60 (78.9) 111 (77.6)
CE  angiotensin-converting enzyme; ARB  angiotensin receptor blocker;
BBB left bundle-branch block; LVEF left ventricular ejection fraction; NYHA
New York Heart Association; RBBB  right bundle-branch block; VT 
entricular tachycardia.able 1. Baseline Characteristics: Patients With and Without
aired Six-Month Echocardiograms
Characteristic
Paired Echo
(n  79)
No Paired Echo
(n  69)
p
Value
ge at implant (yrs)
n 79 169
Mean  SD 66.8  1.2 65.6  10.1 0.41
Range 26.1–82.5 28.9–82.6
ender, n (%)
Male 66 (83.5) 144 (85.2) 0.73
Female 13 (16.5) 25 (14.8)
YHA funtional class, n (%)
II 28 (35.4) 52 (30.8) 0.66
III 46 (58.2) 102 (60.4)
IV 5 (6.3) 15 (8.9)
oncomitant medications,
n (%)
ACE or ARB 68 (86.1) 144 (85.2) 0.86
Beta-blocker 49 (62.0) 70 (41.4) 0.01
Digoxin 56 (70.9) 116 (68.6) 0.72
Diuretic 69 (87.3) 148 (87.6) 0.96
ualifying LVEF (%)
n 79 169
Mean  SD 21.9  6.6 21.1  6.6 0.40
Range 9.0–35.0 5.0–35.0
R interval (ms)
n 79 145
Mean  SD 201  41 207  43 0.30
Range 90–332 88–336
ualifying QRS duration (ms)
n 79 147
Mean  SD 159  27 161  27 0.49
Range 121–237 120–240
esting heart rate, beats/min
n 79 169
Mean  SD 72  13 74  12 0.15
Range 49–108 43–106
ystolic blood pressure
(mm Hg)
n 79 168
Mean  SD 117  18 119  22 0.40
Range 83–170 79–197
iastolic blood pressure
(mm Hg)
n 79 168
Mean  SD 66  10 68  12 0.13
Range 31–88 36–100
rimary tachyarrhythmia,
n (%)
Monomorphic VT 44 (55.7) 104 (61.5) 0.43
Polymorphic VT 8 (10.1) 8 (4.7)
Nonsustained VT 19 (24.1) 39 (23.1)
Ventricular fibrillation 8 (10.1) 18 (10.7)
ther arrhythmias, n (%)
Paroxysmal atrial fibrillation 13 (16.5) 30 (17.8) 0.80
Atrial flutter 4 (5.1) 6 (3.6) 0.57
onduction disorder, n (%)
LBBB 47 (59.5) 86 (50.9) 0.34
RBBB 8 (10.1) 27 (16.0)
Non-specific 24 (30.4) 56 (33.1)
tiology of heart failure,
n (%)
Ischemic 57 (72.2) 110 (65.1) 0.27-mode echocardiography. Twenty-seven (34%) had only
o
T
M
a
F
e
v
t
p
G
m
w
a
s
e
i
g
i
a
p
b
S
(
c
c
c
l
i
m
a
w
d
a
a
s
S
i
s
w
l
A
t
a
s
s
t
m
t
i
s
i
t
 N
2212 Marcus et al. JACC Vol. 46, No. 12, 2005
SPWMD Fails to Predict CRT Outcomes December 20, 2005:2208–14ne of the two walls exhibiting a definite systolic excursion.
he remaining 13 patients (16%) of the cohort with
-mode echocardiograms showed both definitive septal
nd posterior wall deflections. However, as demonstrated in
igure 2, the SPWMD measurement remained difficult
ven when both septal and posterior wall deflections are well
isualized. The difficulty was further confounded by the
hinning and akinesis of infarcted segments frequently
resent in many of these predominantly ischemic patients.
iven the practical limitations of obtaining these measure-
ents, the poor inter-observer reproducibility in our study
as not surprising.
How then can the discrepancies between previous studies
nd our current study be explained? Pitzalis et al. demon-
trated that SPWMD predicted echocardiographic param-
ters of reverse remodeling in 20 patients (20% with
schemic cardiomyopathy) undergoing CRT (9); the same
roup more recently showed that SPWMD predicted clin-
cal benefit in 60 patients (22% with ischemic cardiomyop-
thy) undergoing CRT (8). It is not clear if any of the
atients from the first study were included in the second,
ut, at the most, all of the data supporting the use of
PWMD as a useful predictor stems from 80 patients, 17
21%) of whom had an ischemic cardiomyopathy. Our
ohort included 79 patients, 57 (72%) with an ischemic
ardiomyopathy. Therefore, it is possible that the different
onclusions between the studies are due to the significantly
Table 2. Sensitivity, Specificity, and Positive an
ms for Reverse Remodeling and Clinical Impro
Six-Month Change Sensitivity S
LVESVI reduction of at least 15% 24%
Increase of at least one NYHA
functional class
24%
LVESVI left-ventricular end-systolic volume index; NYHA
wall motion delay.
Table 3. Difference in Six-Month Change in C
Baseline
Measure SP
Six-month change in peak VO2 (ml/kg/min)
n
Mean  SD
Range
Six-month change in 6-min walk (ms)
n
Mean  SD
Range
Six-month change in QOL (points)
n
Mean  SD
Range
Six-month change in NYHA functional class
Improved
No change
WorsenedNYHA  New York Heart Association; QOL  quality of life;
oxygen consumption.arger number of patients with ischemic cardiomyopathies
n our patient group. Indeed, patients with ischemic cardio-
yopathies may be more likely to have focal hypokinesis or
kinesis that would sufficiently perturb septal or posterior
all motion so as to make accurate measurements of systolic
eflections difficult if not impossible. However, separate
nalyses of the 22 patients with non-ischemic cardiomyop-
thy in our study (a number comparable to the original
tudy) (8) also failed to demonstrate any predictive value of
PWMD.
As described in the Methods section, the M-mode
mages in the previous studies were taken in the parasternal
hort-axis view at the level of the papillary muscle (8,9),
hereas our M-mode images were taken in the parasternal
ong-axis view at the tips of the mitral valve leaflets.
lthough it is theoretically possible that a measurement
aken a few millimeters towards the base would make such
significant difference, we doubt that it would rectify the
ignificant difficulties in identifying a definite systolic excur-
ion in one or both walls. If such a difference were found,
his would mean that the measurement at the papillary
uscle would have to be quite precise in location, poten-
ially limiting applicability in clinical practice. In our opin-
on, it is more likely that defining the complex activation
equence of the LV using a single dimensional view is
nherently unreliable independent of the precise location of
he ultrasound beam. Moreover, because septal infarcts tend
egative Predictive Values of SPWMD 130
ent
city
Positive Predictive
Value
Negative Predictive
Value
29% 61%
29% 61%
ew York Heart Association; SPWMD septal-to-posterior
al Response Measures by SPWMD at
D <130 ms SPWMD >130 ms p Value
42 21
 3.1 1.2  2.7 0.29
5 to 8.0 4.2 to 8.7
55 26
 73 41  102 0.97
1 to 229 177 to 249
62 27
7  21 10  20 0.62
7 to 33 41 to 34
(39%) 8 (29%)
(48%) 16 (57%) 0.63
(13%) 4 (14%)d N
vem
pecifi
66%
66%linic
WM
0.4
9.
42
9

6
25
31
8SPWMD  septal-to-posterior wall motion delay; VO2 
t
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December 20, 2005:2208–14 SPWMD Fails to Predict CRT Outcomeso spare the proximal septum, basal beam angulation may
heoretically produce better results in ischemic patients.
evertheless, in their most recent publication, Pitzalis et al.
onsidered the SPWMD to have a value of 0 ms when
eptal akinesis was observed, potentially biasing the results
f the study (8).
Our data, collected in a variety of echocardiography
aboratories across the U.S. and involving a majority of
schemic cardiomyopathy patients, are more representative
f clinical practice than those acquired in a single center
ith a majority of non-ischemic cardiomyopathy patients.
Tissue Doppler imaging (11,15–17), strain rate imaging
11,17), and methods based on phase analysis (18) all show
reat promise in the measurement of intraventricular dys-
ynchrony. One promising method for detecting and mea-
uring dyssynchrony uses an index based on the standard
eviation of the time to peak systolic shortening in 12
yocardial segments: Yu et al. (17) have shown that a
tandard deviation of 33 ms or greater predicts response to
RT with a high degree of sensitivity and specificity . A
imitation of this method is that nearly all of the published
eries have been performed with echocardiographic systems
vailable from a single vendor and the generalizability of
hese measurements to other systems has not been proven.
n contrast, most of the current echocardiographic systems
re capable of recording pulsed tissue Doppler velocities, a
otentially useful measurement that can be used to obtain
iming differences between peak systolic velocities among
ifferent segments. Using this technique, one study demon-
trated that a septal to lateral wall delay of greater than 60
igure 2. This figure illustrates the ambiguous nature of the septal-to-poste
isualized. It is uncertain whether the septal wall deflection should be mea
r at point C where the maximum deflection is seen. The initial septal w
osterior motion resulting from ventricular interaction. The middle of the
eptal wall deflection occurs in diastole.s predicted a favorable response to CRT (15). A recog- eized limitation of the pulsed Doppler technique is that
nly one segment can be recorded in a given cardiac cycle
nd may be influenced by timing shifts from beat to beat
16). These methods remain investigational, are time-
ntensive, and are not currently available in the great
ajority of clinical non-invasive laboratories. On the other
and, although M-mode echocardiography is clinically
idely available and technically easy to perform, our find-
ngs suggest that it should not be used for patient selection
or CRT.
Our study demonstrates that this parameter based on
-mode echocardiography, while attractive in its apparent
implicity, is not adequately robust to be applied in clinical
ractice. A major concern is that patients, especially those
ith ischemic cardiomyopathy, will not be offered this
herapy on the basis of the previously reported studies.
tudy limitations. The major limitation of this study is
hat the M-mode images were not targeted to prospectively
ollect these data. However, all M-mode imaging was
erformed in accordance with the American Society of
chocardiography recommendations. All centers followed a
tandardized protocol, and all echocardiograms were ana-
yzed in an experienced core laboratory.
ONCLUSIONS
eptal-to-posterior wall motion delay based on conventional
-mode echocardiography is not adequate to predict clin-
cal or remodeling response to CRT and therefore should
ot be used to guide CRT patient selection. Because
all motion delay (SPWMD) measurement even when both walls were well
at A, the first deflection, at B, the middle of the larger area of deflection,
flection is too close to the QRS to represent contraction and may reflect
r area of septal wall deflection is appropriately timed while the maximumrior w
sured
all demerging imaging techniques that provide two- and three-
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cal dyssynchrony, they will likely prove superior in selecting
ppropriate patients for CRT and will therefore have an
xpanding role in clinical practice.
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